CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Paradigm Biopharmaceuticals Ltd Company Snapshot
Paradigm Biopharmaceuticals Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Paradigm Biopharmaceuticals Ltd with three other companies in this sector in Australia: Adalta Ltd (2018 sales of 2.08 million Australian Dollars [US$1.48 million] ), Pharmaust Limited (3.30 million Australian Dollars [US$2.34 million] ), and Medibio Ltd (2.60 million Australian Dollars [US$1.85 million] ).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Paradigm Biopharmaceuticals Ltd
  Stock Performance Chart for Paradigm Biopharmaceuticals Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (10/19/2018): .76
(Figures in Australian Dollars)
1 Week -6.8%   13 Weeks -19.7%  
4 Weeks -11.2%   52 Weeks 84.1%  
 
Paradigm Biopharmaceuticals Ltd Key Data:
  Ticker: PAR Country: Australia
  Exchanges: Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 2,736,400
(Year Ending Jan 2019).
Employees: N/A
  Currency: Australian Dollars Market Cap: 93,592,663
  Fiscal Yr Ends: June Shares Outstanding: 123,963,792
  Share Type: Ordinary Closely Held Shares: 54,545,038
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.